Altered retinoic acid receptors

FASEB Journal

Volumn 10, Issue 9, 1996, Pages 955-960

  De Thé, Hugues ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

dominant negative; leukemia; nuclear bodies; transcription

Indexed keywords

ANTINEOPLASTIC AGENT; MUTANT PROTEIN; RECEPTOR SUBUNIT; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; CELL STRAIN HL 60; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME TRANSLOCATION 15; GENE TARGETING; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 0029818553     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.9.8801177     Document Type: Article

References (43)

1. Robertson, K., Emami, B., and Collins, S. (1992) Retinoic acid resistant ML60 cells harbour a point mutation in the RAR ligand binding domain that confers dominant negative activities. Blood 80, 1885-1892
2. Pratt, M., Kralova, J., and McBurney, M. (1990) A dominant negative mutation in RARa in a RA non-responsive embryonal carcinoma cell. Mol. Cell. Biol. 10, 64-13-6453
3. Boylan, J. F., Lufkin, T., Achkar, C. C., Taneja, R., Chambon, P., and Gudas, L. J. (1995) Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol. 15, 843-851
4. Tsai, S., and Collins, S. (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proc. Natl. Acad. Sci. USA 90, 7153-7157
5. Tsai, S., Bartelmez, S., Heyman, R., Damm, K., Evans, K., and Collins, S. (1992) A mutated retinoic acid receptor a exhibiting dominant negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes & Dev. 6, 2258-2269
6. Tsai, S., Bartelmez, S., Sitnicka, E., and Collins, S. (1994) Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid develpoment. Genes & Dev. 8, 2831-2811
7. Saitou, M., Sugai, S., Tanaka, T., Shimouchi, K., Fuchs, E., Naramiya, S., and Kakizuka, A. (1995) Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature (London) 374, 159-162
8. Aneskievich, B., and Fuchs, E. (1995) The A/B domain of truncated RAR can block differentiation and promote features or malignancy. J. Cell. Sci. 108, 195-205
9. Dejean, A., Bougueleret, L., Grzeschiek, K., and Tiollais, P. (1986) Hepatitis virus DNA integration in a sequence homologous to v-erbA and steroid receptors genes in a hepatocellular carcinoma. Nature (London) 322, 70-72
10. Rabbitts, T.H. (1994) Chromosomal translocations in human cancer. Nature (London) 372, 143-149
11. Chomienne, C., Fenaux, P., and Degos, L. (1996) Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10, 1025-1030
12. Warrell, R., de Thé, H., Wang, Z., and Degos, L. (1993) Acute promyelocytic leukemia. New Engl. J. Med. 329, 177-189
13. Chen, Z., Brand, N., Chen, A., Chen, S., Tong, J., Wang, Z., Waxman, S., and Zelent, A. (1993) Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor a locus due to a variant t(11,17) translocalion in acute promyclocytic leukemia. EMBO J. 12, 1161-1167
14. Licht, J. D., Chomienne, C., Coy, A., Chen, A., Scott, A. A., Head, D. R., Michaux, J. L., Wu, Y., DeBlasio, A., Miller, W. H., Jr., Zelenetz, A. D., Willman, C. L., Chen, Z., Chen, S.-J., Zelent, A., Macintyre, E., Veil, A., Cortes, J., Kantarjian, H., and Waxman, S. (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85, 1083-1094
15. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Caub, M. P., Durand, B., Lanotte, M., Berger, R., and Chambon, P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyclocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642
16. Fagioli, M., Alcalay, M., Pandolfi, P. P., Venturini, L., Mencarelli, A., Simeone, A., Acampora, D., Crignani, F., and Pelicci, P. C. (1992) Allemative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7, 1083-1091
17. Goddard, A. D., Yuan, J. Q., Fairbairn, L., Dexter, M., Borrow, J., Kozak, C., and Solomon, E. (1995) Cloning of the murine homolog of the leukemia-associated PM1 gene. Mammal. Genome 6, 732-737
18. Le Douarin, B., Zechel, C., Carnier, J.-M., Lutz, Y., Tore, L., Pierral, B., Heery, D., Gronemeyer, H., Chambon, P., and Losson, R. (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020-2033
19. Reddy, B., Etkin, L., and Freemonl, P. (1992) A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biol. Sci. 17, 344-345
20. Vhadal, L., Maslak, P., Miller, W., Eardley, A., Heller, C., Scheinberg, D., and Warrell, R. (1994) Early mortality and the retinoic acid syndrome in APL: impact of leukocytosis, low dose chemotherapy, PML/RARa isoformand CD13 expression in patients teated with ATRA. Blood 84, 3843-3849
21. Pandolfi, P. P., Alcalay, M., Fagioli, M., Zangrilli, D., Mencarelli, A., Diverio, D., Biondi, A., LoCoco, F., Rambaldi, A., Grignani, F., et al. (1992) Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J. 11, 1397-1407
22. Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., and Chambon, P. (1993) PML/RAR homodimers: distinct binding properties and heteromeric interactions with RXR. EMBO J. 12, 3171-3182
23. Jansen, J. H., Mahfoudi, A., Rambaud, S., Lauvau, C., Wahli, W., and Dejean, A. (1995) Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc. Natl. Acad. Sci. USA 92, 7401-7405
24. Doucas, V., Blockes, J. P., Yaniv, M., de Thé, H., and Dejean, A. (1993) The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. Proc. Natl. Acad. Sci. USA 90, 9345-9349
25. Crignani, F., Ferrucci, P., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Pesehle, C., Nicolelli, I., and Pelicci, P. (1993) The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423-431
26. Kakizuka, A., Miller, W., Jr., Umesono, K., Warrell, R., Jr., Frankel, S. R., Murty, V. V., Dmitrovsky, E., and Evans, R. M. (1991) Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674
27. Daniel, M., Koken, M., Romagné. O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., and de Thé, H. (1993) PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82, 1858-1867
28. Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., and Evans, R. M. (1994) A novel maeromolecular structure is a target of the promyelocyte-retinoic acid receptor oneoprotein. Cell 76, 333-343
29. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., and Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytie leukemia cells. Cell 76, 345-356
30. Koken, M. H. M., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, C., Stuurman, N., de Joug, L., Szostecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E., and de Thé, H. (1994) The t(15;17) translocation alters a nuclear body in a RA-reversible fashion. EMBO J. 13, 1073-1083
31. Szostecki, C., Guldner, H., Netter, H., and Will, H. (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly rrecognized by autoantibodies of patients with primary biliary cirrhosis. J. Immunol. 1445, 4338-4347
32. Brasch, K., and Ochs, R. L. (1992) Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp. Cell. Res. 202, 211-223
33. Stuurman, N., de Graaf, A., Floore, A., Josso, A., Humbel, B., de Jong, L., and van Driel, R. (1992) A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101, 773-784
34. Isomura, T., Tamiya-Koizumi, K., Suzuki, M., Yushida, S., Taniguchi, M., Matsuyama, M., Ishigali, T., Sakuma, S., and Takahashi, M. (1992) RFP is a DNA binding protein associated with the nuclear matrix. Nucleic Acids Res. 20, 5305-5310
35. Takahashi, M., Inaguma, Y., Hiai, H., and Hirose, F. (1988) Developmentally regulated expression of a human finger containing gene encoded by the 5 half of the ret transforming gene. Mol. Cell. Biol. 8, 1853-1856
36. Koken, M. H. M., Linares-Cruz, G., Quignon, F., Viron, A., Chelbi-Alix, M. K., Sobczak-Thépol, J., Juhlin, L., Degos, L., Calvo, F., and de Thé, H. (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315-1324
37. Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, C., and Chang, K. S. (1994) PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14, 6858-6867
38. Stadler, M., Chelbi-Alix, M. K., Koken, M. H. M., Venturini, L., Lee, C., Saïb, A., Quignon, F., Pelicano, L., Guillemin, M.-C., Schindler, C., and de Thé, H. (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11, 2565-2573
39. Doucas, V., Ishov, A., Romo, A., Juguilon, H., Weitzman, M., Evans, R., and Maul, G. (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes & Dev. 10, 196-207
40. Carvalho, T., Seeler, J.-S., Öhman, K., Jordan, P., Pettersson, U., Akusjärvi, G., Carmo-Fonseca, M., and Dejean, A. (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131, 45-56
41. Puvion-Dutilleul, F., Chelbi-Alix, M. K., Koken, M., Quignon, F., Puvion, E., and de Thé, H. (1995) Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body - associated PML protein. Exp. Cell Res. 218, 9-16
42. Lotan, R., Xu, X. C., Lippman, S., Ro, J. Y., Lee, J. S., Lee, J. J., and Hong, W. K. (1995) Suppression of retinoic acid receptor beta in premalignant oral lesions and its up regulation by isotretinoin. N. Engl. J. Med. 332, 1405-1410
43. Chen, J.-Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., and Gronemeyer, H. (1995) RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14, 1187-1197